IN RESPONSE to the growing evidence of the association between smoking and adverse tuberculosis (TB) outcomes, smoking cessation has been recommended for integration into TB treatment programs. 1-5 According to Slama et al., effective delivery of smoking cessation interventions by TB treatment providers requires the following conditions: 1) the provider regards smoking cessation as an essential part of treatment for TB, and not merely a peripheral activity; 2) the provider believes that the intervention can successfully help patients quit; and 3) the provider feels adequately trained and supported with suffi cient resources to deliver the intervention effectively. 6 However, there has been little research into whether these conditions exist in TB treatment facilities and whether smoking cessation interventions can be effectively implemented among TB patients.
IN RESPONSE to the growing evidence of the association between smoking and adverse tuberculosis (TB) outcomes, smoking cessation has been recommended for integration into TB treatment programs. [1] [2] [3] [4] [5] According to Slama et al., effective delivery of smoking cessation interventions by TB treatment providers requires the following conditions: 1) the provider regards smoking cessation as an essential part of treatment for TB, and not merely a peripheral activity; 2) the provider believes that the intervention can successfully help patients quit; and 3) the provider feels adequately trained and supported with suffi cient resources to deliver the intervention effectively. 6 However, there has been little research into whether these conditions exist in TB treatment facilities and whether smoking cessation interventions can be effectively implemented among TB patients.
The objective of this qualitative study was to compare perceptions about smoking cessation among TB patients and their physicians within a large TB hospital in Beijing, China. We also broadly applied the
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Stages of Change Model to explore the extent to which illness with TB causes patients to be more inclined to cessation. 7 Based on this model, the quitting process can be measured by categorizing smokers into stages of readiness to quit: precontemplation, contemplation, preparation, action, and maintenance. 7 The Stages of Change Model has previously been applied in China to characterize population-level readiness to quit. [8] [9] [10] 
STUDY POPULATION AND METHODS

Study population
We recruited physicians and patients at the Beijing Chest Hospital in Beijing, China, from July to August 2010 to participate in focus group discussions (FGDs). Given the sex differences in the epidemiology and social context of smoking and TB, we purposively sampled from a list of attending TB physicians to enroll approximately equal numbers by sex and smoking status to allow for comparison by physician subgroup. 11, 12 However, to ensure confi dentiality, we have not reported the sex of the * p articipant with the responses, particularly as we enrolled only one female doctor who smoked (the national prevalence of smoking among women in China is only 2.4%). 13 For TB patients, we fi rst randomly selected hospitalized patients from the in-patient registration list and conveniently selected patients attending the out-patient clinic for screening. Next, we purposively sampled eligible hospitalized and clinic patients based on operational construct sampling to include approximately equal sample sizes of patients who continued to smoke (precontemplation, contemplation, and preparation stages), and those who quit smoking after TB diagnosis (action and maintenance stages). 7, 14 Eligible patients were aged ⩾18 years, had begun treatment for TB in the past 6 months, and had smoked any time during the 30 days prior to diagnosis with TB.
We sought to assemble homogeneous FGDs composed of similar social and demographic characteristics to facilitate information-rich discussions. 14 However, due to the busy schedule of the TB physicians, we were unable to arrange separate FGDs by sex and smoking status. We conducted separate patient FGDs for younger (age <45 years) and older (age ⩾45 years) patients to minimize the likelihood that the strong age-based social hierarchy prevalent in Chinese culture would stifl e open discussion. Due to the low prevalence of smoking among Chinese women, we were unsuccessful in identifying and recruiting female TB patients who smoked. Furthermore, we did not have suffi cient resources to conduct separate patient FGDs by smoking status, which would have required conducting additional FGDs. Two FGDs of 17 TB physicians and fi ve focus groups of 39 patients were conducted (Table 1) . Given the difference in average income between physicians and typical patients, we sought to provide adequate compensation for study participation while minimizing the risk of coercion by providing participants with different amounts: US$15 for patients and US$30 for physicians.
Data collection
FGDs were conducted by trained moderators at a quiet location in the Beijing Chest Hospital (a conference room and an empty cafeteria). At the start of each focus group discussion, the moderator explained the research project rationale, methods, and the voluntary nature of participation. Written informed consent was obtained from all participants. Consenting participants were asked to complete a baseline questionnaire that included items on demographic characteristics and smoking behavior.
Separate semi-structured moderator guides were developed for doctor and patient focus groups to facilitate in-depth discussions of relevant themes. The moderator guides included questions to elicit discussions on the acceptability of integrating smoking cessation and TB treatment, perceived effectiveness of physician-provided smoking cessation counseling, factors that motivate attempts at quitting, barriers to attempting and achieving cessation, and knowledge regarding the effect of smoking on TB disease. The development of the moderator guide was informed by prior qualitative research on TB treatment and physician's advice to quit smoking. [15] [16] [17] The FGDs were conducted in Chinese and took about 45 min for physicians and 1.5 h for patients. Each discussion was audio recorded, transcribed by a hospital researcher, and translated into English by a bilingual medical student. In addition, fi eld notes and memos were recorded by a physician trained in focus group methodology.
Data analysis
We used qualitative methods described by Miles and Huberman to analyze the study data. 18 After reading the English version of the transcripts multiple times, the fi rst author generated codes representing broad themes. Next, the data were coded with the previously identifi ed themes and entered into a spreadsheet. We then grouped the data into the following participant categories: patients who currently smoked, patients who had quit, physicians who smoked, and physicians who did not smoke, to compare the content of the discussions by participant categories. We did not separate the data from doctors by sex because no sex differences were observed. We also collapsed the patient data into one category, as the data were indistinguishable by smoking status. We reduced the data by constructing a matrix consisting of summaries of the previously defi ned themes by participant categories. Finally, the authors who moderated the focus groups (DX and MC) reviewed the Chinese transcripts and confi rmed the results and interpretation of the translated data.
Ethical considerations
The protocol and study instruments were reviewed and approved by the Institutional Review Boards of San Diego State University and the Beijing ChaoYang Hospital. 
RESULTS
Typical remarks from participants are listed in Table 2 .
Knowledge of the effect of smoking on TB
Patients and physicians were generally aware that smoking adversely affects the outcome of TB disease. However, neither patients nor physicians were familiar with the mechanisms by which smoking affects TB and the extent to which smoking might harm TB patients. Some physicians doubted that smoking affected TB and believed that smoking may be beneficial to some patients. Many doctors expressed interest in obtaining information about the current state of knowledge regarding the TB-smoking relationship.
The following were typical remarks shared during the FGDs. 
Illness with TB as a 'teachable moment'
For most patients, being ill with TB was the primary reason for attempting to quit smoking. Specifi cally, patients quit smoking because it exacerbated their immediate TB symptoms and due to increased concerns about their long-term health after becoming ill with TB. Many had never attempted to quit prior to their illness with TB. Patients also indicated that, because of their TB illness, they were more inclined to follow their physician's advice to quit smoking. However, participants who quit smoking felt that they might return to smoking after they had recovered from their illness. Physicians acknowledged that patients were more likely to accept smoking cessation advice because of their illness, but were concerned that smoking relapse would be common once patients recovered from TB. The following are typical remarks shared by patients and physicians.
I wanted to quit (before becoming ill with TB), but I couldn't. After I became sick, I fi nally quit. 
Effectiveness of TB physician's advice on smoking cessation
Patients reported trusting a physician's recommendations regarding their health overall, but were not able to follow their physician's advice to quit smoking until they became ill with TB. Patients did not feel that physicians provided suffi cient information regarding the health effects of smoking. Patients requested more in-depth smoking-related health education from physicians, including the use of pictures and other concrete examples of the health effects of smoking. Physicians who smoked were concerned that patients would not accept their smoking cessation advice, as patients were at the hospital for TB treatment, and not for smoking cessation treatment.
The patients think that they need to receive treatment for TB, but the doctor wants to treat smoking as well. Will the patient accept this? I think it is hard. (Physician, smoker)
Both smoker and non-smoker physicians believed that smoking cessation advice from physicians who smoked would be ineffective, and proposed that smoking cessation interventions should fi rst be offered to those physicians who smoke.
Physicians' attitudes towards introducing smoking cessation interventions in TB treatment centers
Many doctors were resistant to incorporating smoking cessation as part of their routine treatment for TB due to the diffi culty of adding another task during their already limited time with their patients. Doctors who smoked were particularly opposed to considering smoking cessation as part of their job, and did not feel that additional training in smoking and TB was necessary. In contrast, non-smoker physicians did not feel adequately trained to deliver effective smoking cessation counseling, and expressed interest in receiving training to develop their skills in e videncebased methods for smoking cessation. Sample quotations include:
I think your training should provide us with clear and convincing ways to tell our patient to quit smoking, and ways to assess patients (to provide appropriate intervention). (Physician, non-smoker)
I am very busy in the clinic. I don't even have the time to drink water or go to the bathroom. I don't have time to talk about smoking cessation. (Physician, smoker)
Is it legal for TB doctors to help patients quit smoking? I think it is beyond our job description.
(Physician, smoker) 
DISCUSSION
To our knowledge, the present study is the fi rst to describe the perspectives of TB patients and providers regarding the provision of a smoking cessation intervention as part of TB treatment. By utilizing focus group-based qualitative methods to facilitate indepth, interactive discussions, we were able to gain new insights into a topic that has not been adequately studied in the past. For example, we found evidence that patients receiving treatment for TB are indeed at a 'teachable moment' for smoking cessation advice. 6 Patients who were advised to quit smoking by their physicians after diagnosis with TB were likely to progress in their stage membership and attempt to quit smoking. However, patients and physicians were concerned about the likelihood of smoking relapse after patients recovered from TB. This fi nding is consistent with studies that show a high rate of smoking relapse among recovered TB patients who had quit during their illness. 19, 20 Educational messages for smoking cessation counseling should therefore focus on cessation maintenance and address the full range of harms caused by smoking, including those not related to TB, as well as the possibility of increased susceptibility to relapse or re-infection with TB after initial recovery. [21] [22] [23] We also found that many physicians, particularly those who were smokers, did not view smoking cessation as an integral part of TB treatment and did not believe that their patients would accept smoking cessation counseling. In contrast, patients expected to receive smoking cessation advice from their TB physicians and readily accepted the notion that smoking cessation should be part of their treatment for TB. Successful integration of smoking cessation with TB treatment may fi rst require changing TB doctors' perceptions about their role in the delivery of smoking cessation interventions. Particular attention should be given to engaging and securing support for smoking cessation from TB physicians who are smokers. TB physicians should also be engaged to jointly address concerns about the additional workload associated with instituting formal smoking cessation interventions as part of TB treatment programs.
One unexpected fi nding from both physicians and patients was the importance placed on the health care environment in helping or hindering patients' attempts to quit smoking. China recently enacted a law that requires all hospitals to be smoke-free by the end of 2011. 24 While there are still signifi cant barriers to full implementation of this policy, the institution and enforcement of smoke-free policies in TB treatment facilities is likely to contribute to successful implementation of smoking cessation programs. 24 An important limitation to the study fi ndings is that the focus groups were conducted in one TB hospital in Beijing, China. While we attempted to enroll a diverse study population, including participants receiving in-patient and out-patient care and varying age groups, our fi ndings may not be generalizable to TB patients and providers in other TB facilities. In addition, we were not able to conduct FGDs separately for smokers and non-smokers. Conducting separate FGDs by smoking status might elicit deeper group interaction and more information-rich results. We were also unsuccessful in recruiting female smokers with TB. Additional research should be conducted among female smokers with TB to ensure that their perspectives are incorporated into the design of smoking cessation programs.
Our study provides timely information to guide the development of smoking cessation interventions for implementation in TB treatment facilities. In the light of the enormous burden of disease posed by smoking and TB and the evidence of their synergy, randomized controlled trials to evaluate the effectiveness of well-designed interventions are urgently needed. Stronger partnerships between TB and tobacco control programs should also be forged to ensure optimal use of resources in combating the dual epidemics. Los pacientes fueron más receptivos al consejo de los médicos de abandonar el tabaquismo, debido a una mayor preocupación por su salud después de haber contraído la TB; sin embargo, señalaron también la posibilidad de reiniciar el consumo de tabaco, una vez recuperados de la enfermedad. Un obstáculo a los intentos de abandono del hábito por parte de los pacientes pudo ser su exposición al tabaco en la institución de tratamiento de la TB. Los conocimientos de los médicos sobre los efectos del tabaquismo en la TB eran deficientes y muchos de ellos, sobre todo los que fumaban, no consideraban la intervención en favor del abandono del hábito como parte integrante del tratamiento antituberculoso. C O N C L U S I Ó N : Pese a la oportunidad de impartir una educación durante el tratamiento antituberculoso, existen aun obstáculos considerables al abandono del tabaquismo por parte de los pacientes. La educación del paciente en los programas de tratamiento de la TB debe abordar los efectos específicos del tabaco sobre la TB y las ventajas generales que aporta a la salud el abandono de su consumo. Es primordial implementar firmemente las políticas de ambientes sin humo en los establecimientos de tratamiento antituberculoso. La integración eficaz del abandono del tabaquismo a los programas de tratamiento de la TB exige que los profesionales adopten estas intervenciones como una parte central del tratamiento de la enfermedad.
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